You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bepotastine besilate

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Safety, Tolerability, Ocular Surface Trial in Guadalajara (Bepotastine Besilate)

Completed
  • Safety
  • +3 more
  • Bepotastine Besilate
  • Guadalajara, Jalisco, Mexico
    Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 22, 2021

Seasonal Allergic Rhinitis Trial in Irvine (bepotastine besilate nasal product - low dose, bepotastine besilate nasal product -

Completed
Has Results
  • Seasonal Allergic Rhinitis
  • bepotastine besilate nasal product - low dose
  • +3 more
  • Irvine, California
    ISTA Pharmaceuticals, Inc.
Oct 1, 2020

Seasonal Allergic Rhinitis Trial in Irvine (Bepotastine Besilate Nasal Spray 2% Twice a day, Bepotastine Besilate Nasal Spray 3%

Completed
Has Results
  • Seasonal Allergic Rhinitis
  • Bepotastine Besilate Nasal Spray 2% Twice a day
  • +3 more
  • Irvine, California
    ISTA Pharmaceuticals, Inc.
Oct 1, 2020

Seasonal Allergic Rhinitis Trial in Irvine (Bepotastine besilate formulation, Fluticasone propionate, Bepotastine

Completed
Has Results
  • Seasonal Allergic Rhinitis
  • Bepotastine besilate formulation
  • +3 more
  • Irvine, California
    ISTA Pharmaceuticals, Inc.
Oct 1, 2020

Seasonal Allergic Rhinitis Trial in Irvine (Bepotastine besilate, Placebo)

Completed
Has Results
  • Seasonal Allergic Rhinitis
  • Bepotastine besilate
  • Placebo
  • Irvine, California
    Bausch & Lomb Incorporated
Oct 1, 2020

Allergic Conjunctivitis Trial in Irvine (bepotastine besilate ophthalmic solution, comparator ophthalmic solution)

Completed
Has Results
  • Allergic Conjunctivitis
  • bepotastine besilate ophthalmic solution
  • placebo comparator ophthalmic solution
  • Irvine, California
    ISTA Pharmaceuticals, Inc.
Sep 11, 2020

Allergic Conjunctivitis Trial in Caba (Bepotastine Besilate 1.5% PF, Olopatadine Hydrochloride 0.2% BAK)

Recruiting
  • Allergic Conjunctivitis
  • Bepotastine Besilate 1.5% PF
  • Olopatadine Hydrochloride 0.2% BAK
  • Caba, Argentina
  • +3 more
Mar 29, 2021

Healthy Trial in Seoul (Fisrt period TWLO_C, Fisrt period TWLO, Washout period)

Completed
  • Healthy
  • Fisrt period TWLO_C
  • +4 more
  • Seoul, Korea, Republic of
    H Plus Yangji Hospital
Feb 6, 2020

Allergic Conjunctivitis Trial in Minneapolis (Refresh Tears 0.5% Lubricant Eye Drops, Bepreve 1.5% Ophthalmic Solution)

Completed
Has Results
  • Allergic Conjunctivitis
  • Refresh Tears 0.5% Lubricant Eye Drops
  • Bepreve 1.5% Ophthalmic Solution
  • Minneapolis, Minnesota
    Minnesota Eye Consultants, P.A.
Mar 19, 2020

Allergic Rhinitis, Cough Trial (Bepotastine, Placebo)

Completed
  • Allergic Rhinitis
  • Cough
  • Seoul, Korea, Republic of
    Asan medical center
Jan 3, 2023

Allergic Conjunctivitis Trial in Fullerton (bepotastine besilate, 1.5%, Loteprednol etabonate)

Completed
Has Results
  • Allergic Conjunctivitis
  • bepotastine besilate, 1.5%
  • Loteprednol etabonate
  • Fullerton, California
  • +1 more
Jul 16, 2019

Dermatitis, Atopic Trial in Hokkaido (Bepotastine besilate, ketotifen fumarate)

Completed
Has Results
  • Dermatitis
  • Atopic
  • Bepotastine besilate
  • ketotifen fumarate
  • Hokkaido, Japan
    Medical Corporation Kojinkai Asanuma Dermatology Clinic
Sep 28, 2017

Hypertension, Coronary Atherosclerosis Trial in Tokyo (Calcium channel blockers (amlodipine, azelnidipine))

Completed
  • Hypertension
  • Coronary Atherosclerosis
  • Calcium channel blockers (amlodipine, azelnidipine)
  • Tokyo, Japan
    Department of Cardiology, Juntendo University School of Medicine
May 12, 2021

Healthy Volunteers Trial in Amman (Ramipril, Amlodipine and Atorvastatin)

Completed
  • Healthy Volunteers
  • Ramipril, Amlodipine and Atorvastatin
  • Amman, Jordan
    International Pharmaceutical Research Center
Feb 7, 2020

Healthy Volunteers Trial in Amman (Candesartan, Amlodipine, Atorvastatin)

Completed
  • Healthy Volunteers
  • Candesartan, Amlodipine, Atorvastatin
  • Amman, Jordan
    International Pharmaceutical Research Center
Jan 31, 2020

Rhinitis, Allergic, Perennial Trial in Seoul (HL151, TALION tab.)

Completed
  • Rhinitis, Allergic, Perennial
  • Seoul, Korea, Republic of
    The Korea Univertisy Anam Hospital
Aug 16, 2018

Rhinitis, Allergic, Perennial Trial in Seoul (HL151, TALION tab.)

Completed
  • Rhinitis, Allergic, Perennial
  • Seoul, Korea, Republic of
    The Korea Univertisy Anam Hospital
Aug 16, 2018

Perennial Allergic Rhinitis Trial in Kanagawa (Bepotastine besilate)

Completed
Has Results
  • Perennial Allergic Rhinitis
  • Bepotastine besilate
  • Kanagawa, Japan
    Reserch site
Mar 10, 2016

Candesartan Cilexetil/Amlodipine Besilate Combination Tablets

Completed
Has Results
  • Hypertension
  • Candesartan cilexetil/Amlodipine besilate
  • (no location specified)
Jul 25, 2018

Healthy Trial in Seoul (DA-5206(Fasting), DA-5206(Fed), TALION®)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Jul 6, 2017

Perennial Allergic Rhinitis Trial in Fukuoka, Toyama (Bepotastine besilate, Placebo)

Completed
Has Results
  • Perennial Allergic Rhinitis
  • Bepotastine besilate
  • Placebo
  • Fukuoka, Japan
  • +1 more
Nov 10, 2015

Healthy Trial (Erdos, Talion, Erdos, Talion)

Completed
  • Healthy
  • (no location specified)
Jan 4, 2015

Perennial Allergic Rhinitis Trial in Japan (TAU-284, Placebo)

Completed
Has Results
  • Perennial Allergic Rhinitis
  • Chubu, Japan
  • +4 more
Nov 10, 2015

Eye Allergies Trial in Murfreesboro (Olopatadine HCl 0.2%, Bepotastine besilate ophthalmic solution 1.5%)

Completed
  • Eye Allergies
  • Olopatadine hydrochloride 0.2%
  • Bepotastine besilate ophthalmic solution 1.5%
  • Murfreesboro, Tennessee
    McCabe Vision Center
Jan 8, 2014

Healthy Trial in Seoul (CJ-30044, TALION TAB. 10mg)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Yonsei university severance hospital
Aug 15, 2013